05:42 PM EST, 01/28/2025 (MT Newswires) -- Maravai Lifesciences ( MRVI ) acquired intellectual property and relevant assets from Molecular Assemblies for an undisclosed price.
The acquisition will expand customer development of next-generation mRNA and CRISPR nucleic acid-based therapies, Maravai said Tuesday in a statement.